NIVF

Market Cap

$1.13M

P/E Ratio

—

EPS

$486.09

Dividend Yield

0.00%

52-Week Range

$1.80 — $4440.00

Volume

167.31K

Avg Volume

189.22K

Beta

0.00

P/E (TTM)

—

Forward P/E

0.08

PEG Ratio

0.00

P/S (TTM)

0.54

P/B (TTM)

0.05

P/FCF

—

EV/EBITDA

—

EV/Sales

—

ROE (TTM)

1.17%

ROA (TTM)

0.47%

ROIC

—

Gross Margin

0.19%

Operating Margin

-1.41%

Net Margin

—

Debt/Equity

0.19

Current Ratio

3.43

EPS Growth (YoY)

—

Revenue Growth (YoY)

—

EPS Growth (3Y)

+4305.80%

EPS Growth (5Y)

+3229.35%

Sales Growth (3Y)

+0.12%

Sales Growth (5Y)

+0.09%

EPS Est (This Year)

$23.85

EPS Est (Next Year)

$95.26

Dividend Yield

—

Annual Dividend

—

Payout Ratio

—

Frequency

—

Ex-Dividend Date

—

Cash/Share

$2.59

Institutional %

—

Inst. Net Change

—

Insider Net Shares (90d)

—

Outstanding Shares

24.38K

Float

24.19K

Free Float %

99.20%

Sector

Healthcare

Industry

Medical - Healthcare Plans

Country

TH

Exchange

NASDAQ

IPO Date

2022-03-18

Employees

76

CEO

Wing Fung Siu

Index Membership

—

Website

https://newgenivf.com